SGC-CDKL5_GSK3

SGC-CDKL5_GSK3 : ATP competitive, Inhibitor of CDKL5, GSK3A, GSK3B

Structure

Information

  • CDKL5
  • GSK3A
  • GSK3B
  • ATP competitive
  • Inhibitor
  • up to 500 nM

In Vitro Validations

Uniprot ID: O76039
Target Class: Kinase
Target SubClass: CMGC
Potency: IC50
Potency Value: 6.5 nM
Potency Assay: CDKL5 Split luciferase assay
PDB ID for probe-target interaction (3D structure): 8CIE
Target aliases:
Cyclin-dependent kinase-like 5, STK9, CDKL5, CDKL5 ...

DOI Reference: 10.1021/acschemneuro.3c00135

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Potency assay (off target): Compounds 2 and 4, were analysed at 1 μM in the Eurofins DiscoverX scanMAX panel, assessing binding to 403 Kinases: both compounds were shown to be selective for CDKL5 except for GSK3a/b. Within the CDKL family, compound 2 was selective, showing DiscoverX percent control values of 89 (CDKL2), 95 (CDKL1) and 100 (CDKL3).
Potency assay, off target (cells): NanoBRET assay for closest off-target CDK16 and related CDK17: IC50 of 1.9 μM for bot targets
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

SERP Comments:

The probe is highly potent in cellular and cell free settings, was assessed thoroughly and screened against a panel of 402 kinases (Eurofins DiscoverX scanMAX) without any additional off targets. A control compound that only targets GSK3 is provided and should be used to assess CDKL5 mediated effects. Considering the selectivity limitations, the probe is recommendable. Additional note: The group who reported the probe by now reported a full selective probe on CDKL5 (10.7554/eLife.88206).

(last updated: 17 Jun 2024 )

SERP+ Ratings

In Cell Rating

(last updated: 23 Sept 2024 )